Imatinib as the first-line treatment of patients with chronic myeloid leukemia diagnosed in the chronic phase: can we compare real life data to the results from clinical trials?

Am J Hematol

Department of Internal Medicine Hematology and Oncology, University Hospital and Masaryk University, Brno, Czech Republic.

Published: March 2011

Download full-text PDF	Source
http://dx.doi.org/10.1002/ajh.21942	DOI Listing

Publication Analysis

imatinib first-line

first-line treatment

treatment patients

patients chronic

chronic myeloid

myeloid leukemia

leukemia diagnosed

diagnosed chronic

chronic phase

phase compare

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!